Authors:
STARACE F
BALDASSARRE C
BIANCOLILLI V
FEA M
SERPELLONI G
BARTOLI L
MAJ M
Citation: F. Starace et al., EARLY NEUROPSYCHOLOGICAL IMPAIRMENT IN HIV-SEROPOSITIVE INTRAVENOUS-DRUG-USERS - EVIDENCE FROM THE ITALIAN MULTICENTER NEUROPSYCHOLOGICAL HIV STUDY, Acta psychiatrica Scandinavica, 97(2), 1998, pp. 132-138
Authors:
PEZZOTTI P
PIOVESAN C
REZZA G
MORO G
SERPELLONI G
FERRARO P
Citation: P. Pezzotti et al., COMBINING HIV AND AIDS SURVEILLANCE - AN EXPERIENCE FROM AN ITALIAN REGION, International journal of epidemiology, 26(6), 1997, pp. 1352-1358
Citation: G. Serpelloni et al., INTEREST IN HIV VACCINES AMONG ITALIAN INJECTION-DRUG USERS, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 206-207
Authors:
DORRUCCI M
REZZA G
VLAHOV D
PEZZOTTI P
SINICCO A
NICOLOSI A
LAZZARIN A
GALAI N
GAFA S
PRISTERA R
ANGARANO G
SERPELLONI G
CASTELLI F
VIALE P
SALASSA B
RICCHI E
BARBANERA M
ORTONA L
TIRELLI U
AIUTI F
CANESSA A
ZERBONI R
ZACCARELLI M
CIAFFI L
ALLIEGRO B
LEPRI AC
Citation: M. Dorrucci et al., CLINICAL CHARACTERISTICS AND PROGNOSTIC VALUE OF ACUTE RETROVIRAL SYNDROME AMONG INJECTING DRUG-USERS, AIDS, 9(6), 1995, pp. 597-604
Authors:
REZZA G
DORRUCCI M
PEZZOTTI P
PRISTERA R
SERPELLONI G
Citation: G. Rezza et al., EVALUATION OF SYMPTOMS SUGGESTIVE OF HIV ACUTE DISEASE AMONG INJECTING DRUG-USERS, The Journal of infection, 30(3), 1995, pp. 263-264
Authors:
SERPELLONI G
CARRIERI MP
REZZA G
MORGANTI S
GOMMA M
BINKIN N
Citation: G. Serpelloni et al., METHADONE TREATMENT AS A DETERMINANT OF HIV RISK REDUCTION AMONG INJECTING DRUG-USERS - A NESTED CASE-CONTROL STUDY, AIDS care, 6(2), 1994, pp. 215-220
Authors:
REZZA G
SALMASO S
ABENI D
BRANCATO G
ANEMONA A
ROVETTA C
VERANI P
PERUCCI CA
CARBALLO M
SERPELLONI G
GALVAN U
MANCONI PE
MELONI D
PIRO R
SOLINAS C
PETRELLA M
NESPOLI M
LAZZARIN A
ZANON L
ZAMPIERI F
Citation: G. Rezza et al., HIV PREVALENCE AND FREQUENCY OF RISK BEHAVIOR IN INJECTING DRUG-USERSENTERING TREATMENT AND OUT OF TREATMENT - A CROSS-SECTIONAL STUDY IN 5 ITALIAN CITIES, Journal of drug issues, 24(3), 1994, pp. 527-535